SCI Pharmtech Inc Financial Flexibility Index
SCI Pharmtech Inc financial flexibility index. SCI Pharmtech Inc (4119) has a Financial Flexibility Index of 0.13x as of June 2026. Free cash flow of NT$217.75 Million (operating CF NT$156.75 Million minus capex NT$60.99 Million) represents 0% of total liabilities (NT$1.62 Billion). Explore SCI Pharmtech Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SCI Pharmtech Inc (2002–2025)
Financial flexibility index of SCI Pharmtech Inc from 2002 to 2025. Historical Financial Flexibility Index trend for SCI Pharmtech Inc across 23 annual periods. Check SCI Pharmtech Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SCI Pharmtech Inc Financial Flexibility Index by Year (2002–2025)
SCI Pharmtech Inc financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for SCI Pharmtech Inc. For the full cash flow conversion analysis, see cash efficiency ratio of SCI Pharmtech Inc.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | NT$830.32 Million | NT$220.32 Million | NT$1.49 Billion | ▼ -46.9% |
| 2024 | 1.05x | NT$1.81 Billion | NT$860.52 Million | NT$1.72 Billion | ▲ +33.9% |
| 2023 | 0.78x | NT$1.25 Billion | NT$215.77 Million | NT$1.59 Billion | ▼ -28.8% |
| 2022 | 1.10x | NT$1.46 Billion | NT$296.56 Million | NT$1.33 Billion | ▼ -9.4% |
| 2021 | 1.21x | NT$1.06 Billion | NT$280.28 Million | NT$869.26 Million | ▲ +27.4% |
| 2020 | 0.95x | NT$1.19 Billion | NT$971.53 Million | NT$1.25 Billion | ▼ -41.9% |
| 2019 | 1.64x | NT$996.08 Million | NT$791.60 Million | NT$606.84 Million | ▲ +47.9% |
| 2018 | 1.11x | NT$642.63 Million | NT$480.18 Million | NT$578.85 Million | ▼ -5.3% |
| 2017 | 1.17x | NT$429.04 Million | NT$281.65 Million | NT$365.88 Million | ▼ -17.2% |
| 2016 | 1.42x | NT$679.31 Million | NT$502.11 Million | NT$479.43 Million | ▲ +11.8% |
| 2015 | 1.27x | NT$880.75 Million | NT$663.24 Million | NT$695.02 Million | ▲ +73.2% |
| 2014 | 0.73x | NT$727.92 Million | NT$358.77 Million | NT$994.64 Million | ▼ -28.8% |
| 2013 | 1.03x | NT$1.01 Billion | NT$238.57 Million | NT$984.62 Million | ▼ -41.8% |
| 2012 | 1.76x | NT$566.47 Million | NT$385.57 Million | NT$321.12 Million | ▲ +71.1% |
| 2011 | 1.03x | NT$397.26 Million | NT$249.55 Million | NT$385.26 Million | ▼ -5.9% |
| 2010 | 1.10x | NT$409.30 Million | NT$218.96 Million | NT$373.37 Million | ▼ -52.8% |
| 2009 | 2.32x | NT$498.09 Million | NT$316.96 Million | NT$214.32 Million | ▲ +15.3% |
| 2008 | 2.02x | NT$383.42 Million | NT$245.29 Million | NT$190.16 Million | ▲ +6.5% |
| 2007 | 1.89x | NT$334.74 Million | NT$167.53 Million | NT$176.74 Million | ▼ -38.8% |
| 2006 | 3.09x | NT$293.62 Million | NT$131.62 Million | NT$94.94 Million | ▲ +255.8% |
| 2004 | 0.87x | NT$112.16 Million | NT$76.61 Million | NT$129.03 Million | ▼ -70.9% |
| 2003 | 2.98x | NT$307.15 Million | NT$206.86 Million | NT$102.99 Million | ▲ +416.4% |
| 2002 | 0.58x | NT$148.85 Million | NT$107.12 Million | NT$257.76 Million | — |